|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0027540,
umls-concept:C0030705,
umls-concept:C0036043,
umls-concept:C0038013,
umls-concept:C0087111,
umls-concept:C0205210,
umls-concept:C0205322,
umls-concept:C0332120,
umls-concept:C0332307,
umls-concept:C0439234,
umls-concept:C0666743,
umls-concept:C0871261,
umls-concept:C1521761,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2003941,
umls-concept:C2911692
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-22
|
|
pubmed:abstractText |
There is insufficient evidence for the long-term efficacy and safety of anti-tumour necrosis factor therapy in patients with ankylosing spondylitis (AS). This is the first report on the treatment with infliximab over 5 years.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
pubmed-author:AlteaEE,
pubmed-author:BaraliakosXX,
pubmed-author:BraunJJ,
pubmed-author:BurmesterGG,
pubmed-author:FritzCC,
pubmed-author:KrauseAA,
pubmed-author:ListingJJ,
pubmed-author:SörensenHH,
pubmed-author:ScheweSS,
pubmed-author:SchneiderMM,
pubmed-author:SieperJJ,
pubmed-author:ZeidlerHH
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
67
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
340-5
|
|
pubmed:meshHeading |
pubmed-meshheading:17967831-Adult,
pubmed-meshheading:17967831-Antibodies, Monoclonal,
pubmed-meshheading:17967831-Antirheumatic Agents,
pubmed-meshheading:17967831-Drug Administration Schedule,
pubmed-meshheading:17967831-Female,
pubmed-meshheading:17967831-Follow-Up Studies,
pubmed-meshheading:17967831-Humans,
pubmed-meshheading:17967831-Male,
pubmed-meshheading:17967831-Middle Aged,
pubmed-meshheading:17967831-Remission Induction,
pubmed-meshheading:17967831-Severity of Illness Index,
pubmed-meshheading:17967831-Spondylitis, Ankylosing,
pubmed-meshheading:17967831-Treatment Outcome,
pubmed-meshheading:17967831-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Persistent clinical efficacy and safety of anti-tumour necrosis factor alpha therapy with infliximab in patients with ankylosing spondylitis over 5 years: evidence for different types of response.
|
|
pubmed:affiliation |
Rheumatology Medical Center Ruhrgebiet, Herne, Germany. j.braun@rheumazentrum-ruhrgebiet.de
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Multicenter Study
|
